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Abstract
Background: Ca
2+-mediated regulation of ion channels provides a link between intracellular signaling pathways and
membrane electrical activity. Intracellular Ca
2+ inhibits the voltage-gated potassium channel EAG1 through the direct
binding of calmodulin (CaM). Three CaM binding sites (BD-C1: 674-683, BD-C2: 711-721, BD-N: 151-165) have been identified
in a peptide screen and were proposed to mediate binding. The participation of the three sites in CaM binding to the native
channel, however, remains unclear.
Methodology/Principal Findings: Here we studied the binding of Ca
2+/CaM to the EAG channel by visualizing the
interaction between YFP-labeled CaM and Cerulean-labeled hEAG1 in mammalian cells by FRET. The results of our cellular
approach substantiate that two CaM binding sites are predominantly involved; the high-affinity 1-8-14 based CaM binding
domain in the N-terminus and the second C-terminal binding domain BD-C2. Mutations at these sites completely abolished
CaM binding to hEAG1.
Conclusions/Significance: We demonstrated that the BD-N and BD-C2 binding domains are sufficient for CaM binding to
the native channel, and, therefore, that BD-C1 is unable to bind CaM independently.
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Introduction
Ether-a `-go-go (EAG) channels mediate inward-rectifying potassi-
um currents with activation close to the membrane resting
potential. They are reported to be modulated by intracellular
Ca
2+ levels [1,2], a feature that is likely to play a role in their
proposed functions in cell proliferation [3], differentiation
(myoblast fusion) [4] and regulation of neuronal activity [5,6,7].
EAG channels are the founding members of the the KCNH or
ether-a-go-go related family of voltage-gated K
+ channels [8].
EAG-family channels are structurally characterized by the
presence of the highly conserved EAG or PAS (Per-Arnt-Sim)
domain in their N-termini [9]. Their currents, however, can differ
significantly from those of EAG1 or EAG2. Functional EAG
channels are tetramers and both hEAG1 and hEAG2 have been
shown to form functional heterotetramers upon co-expression
[10]. EAG channel subunits are multipass membrane proteins
with six trans-membrane segments (S1-S6) and intracellular tails at
the N- and C-termini, a standard topology which is shared by
other voltage-gated K
+ channels [11]. The cytoplasmic regions at
the N- and C-termini of the channel comprise over 70% of the
aminoacid sequence and contain several functional domains. The
N-terminus includes a CaM binding domain (BD-N) and the PAS
domain. The latter appears to play a role in channel gating by
binding to the S4-S5 intracellular loop [9,12]. The cytoplasmic C-
terminus region contains four regulatory domains- a putative, and
apparently non-functional, cyclic nucleotide (cNMP) binding
domain [13,14], two CaM binding domains (BD-C1 and BD-
C2) and a tetramerization-mediating domain [15,16].
hEAG1 was found to be inhibited by Ca
2+, revealing a half-
maximal inhibition at a Ca
2+ concentration of ,100 nM [1,2].
This implies that EAG channel activity is inhibited just above
resting Ca
2+-levels. Initially, Scho ¨nherr et al. [17] reported that
the inhibition of hEAG1 by Ca
2+ was mediated by the direct
binding of Ca
2+/CaM to the C-terminus (AA 707–726) of the
channel. This stretch of residues harbors a putative amphiphilic
CaM-binding helix (BD-C2: 711–720). More recently, two further
putative CaM binding domains were found [18] using a peptide
scanning approach, one in the N- (BD-N: AA 151–165) and
another in the C-terminus (BD-C1: AA 674–683) of hEAG1.
Mutations in each of these domains were reported to impair the
inhibition of hEAG1 currents by Ca
2+. Little is presently known
about the contribution of BD-C1 to the binding of CaM.
Fluorescence Correlation Spectroscopy (FCS) affinity assays
indicated that CaM binding to this site is of lower affinity as
compared to the other sites [18], raising doubts on whether it
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C2. This kind of ambiguity in the results of biochemical assays for
ion-channel interacting proteins is not uncommon. Usually, only
the cytosolic portions of channels are assayed and these may not
acquire the conformation of the native tetrameric membrane-
inserted channel. For these reasons, and in contrast to previous
screens, we developed an assay based on Fo ¨rster Resonance
Energy Transfer (FRET) to investigate the binding of CaM to the
full-length hEAG1 channel in cells, directly. We show that BD-C1
is not able to bind CaM to the channel on its own and that binding
to the N-terminus and the C-terminal BD-C2 suffices.
Methods
Plasmid construction and mutagenesis
The C-terminal Cerulean- and YFP-fusion constructs of full-
length hEAG1 were created by cloning the cDNA of hEAG1 into
the CB6 vector using KpnI and NotI restriction sites. Cerulean
and YFP were cloned at the C-terminal of hEAG1 by PCR using
NotI and BamHI sites. The Cerulean- and YFP- fusion constructs
of the C-terminus of hEAG1 were cloned by amplifying the
segment M478-S962 of hEAG1 by PCR and inserting it between
the BamHI and NotI sites of the pcDNA3 vector (Invitrogen).
Cerulean and YFP were then amplified by PCR with flanking
NotI sites and inserted downstream of the C-terminus of hEAG1.
The Glutathione S-transferase (GST)-fusion construct of the N-
terminus of rEAG1 was obtained by PCR amplification of the
fragment AA 1–219 and subsequent subcloning between BamHI
and NotI restriction sites in the pGEX-4T-1 vector (Pharmacia/
GE Healthcare).
The cDNA for rat calmodulin II was amplified by PCR with
flanking NotI restriction sites and cloned into the CB6-N-YFP
vector to generate N-terminally YFP-labeled calmodulin (YFP-
CaM). Point mutations in the CaM binding sites of rat and human
EAG1 were generated using the PCR-based QuickChange XL
mutagenesis kit (Stratagene). All constructs were verified by
sequencing.
Cerulean was kindly provided by D. Piston, Vanderbilt
University, Nashville, TN, USA, the YFP-CB6 vector[19] was a
kind gift from M. Way, Cancer Research UK, London, UK, the
cDNA for rat calmodulin II was kindly provided by T M. Shea,
University of Iowa, Iowa City, IA, USA and the YFP-apo-
Calmodulin (YFP-apoCaM [20]) was a gift from D. Yue, Johns
Hopkins University, Baltimore, MD, USA. Mutations in all EF-
hand domains render this version of CaM insensitive to Ca
2+.
Cell culture and transfection
HEK-293 cells were cultured in DMEM: F12 (1:1) (Gibco),
supplemented with 10% Fetal Calf Serum and 0.1% streptomy-
cin/penicillin (Gibco) in a humidified atmosphere with 5% CO2 at
37uC. Cells were seeded on poly-L-lysine-coated glass coverslips
and transfected at 20–30% confluency using FuGene6 (Roche),
according to the instructions of the manufacturer. The total
amount of cDNA used was 0.5 mg per 15 mm cover slip. For co-
transfections, a hEAG1:CaM cDNA ratio of 3:1 (m/m) was used.
Ca
2+-ionophore treatment and sample preparation
For FRET measurements on CaM binding, cells were treated
36 hrs after transfection with 1 mM ionomycin (Calbiochem) in
either Ca
2+-containing Ringer solution (145 mM NaCl, 25 mM
HEPES pH 7.4, 5.4 mM KCl, 5 mM Glucose, 1.8 mM CaCl2,




2+ -free Ringer solution with 1 mM EGTA (denoted
‘‘-Ca
2+’’), for 10 min at 37uC and subsequently fixed for 25 min
with 4% formaldehyde. After fixation, cells were briefly washed in
PBS and mounted in Mowiol.
Microscopy
Cells were imaged on a Leica DMIRE2 inverted microscope
equipped with a TCS SP2 (AOBS) confocal scanner and a 63x
NA1.4 HCX PL Apo objective (Leica). Fluorescence Resonance
Energy Transfer (FRET) was measured by Acceptor Photobleach-
ing [21]. Cerulean and YFP were excited using the 458 and
514 nm lines of an Argon laser, respectively. Cerulean emission
was recorded in the spectral window of 470–505 nm and YFP at
525–610 nm. The use of 458 nm for Cerulean excitation avoids
photoconversion effects of YFP [22]. For FRET efficiency
measurements, images of the donor (Cerulean) and acceptor
(YFP) were acquired before and after photo-destruction of YFP to
15% of its initial intensity in a selected region of interest. Image
size was 102461024 pixels and each line was averaged over two
consecutive line-scans. The unbleached areas were used as a
control for sample movement or laser power fluctuations. Pixels
from these areas were included in our analysis (denoted ‘Control’)
as a baseline reference. Photomultiplier gain and offset values, as
well as laser intensities were set to maximize linearity and kept
constant for the images acquired before and after bleaching of the
acceptor fluorophore. The pinhole opening was maximally opened
during acquisition (5.2 Airy units).
Image analysis and quantification
Image analysis was performed with the Matlab 7.0 suite (The
Mathworks) using custom-written scripts. In brief, donor images
were binned (262) and subsequently subjected to a low-pass
Wiener and Gaussian filter with 363 kernel dimensions. Images
were background-subtracted and thresholded on fluorescence
intensity. FRET efficiencies (E) were calculated on a pixel-to-pixel
basis by determining the difference between donor intensities
before (Dpre) and after photobleaching (Dpost) of the acceptor
and normalizing to the donor intensity after photobleaching
(E=1-(Dpre/Dpost)). The FRET efficiencies are represented in
pseudo-color for better visualization. Cumulative FRET efficiency
distribution histograms for each experimental condition were
obtained by normalization of the cumulative FRET efficiencies
per pixel of several cells to the number of pixels analyzed in
regions of interest (or unbleached control areas) and the number of
cells for each condition. These distributions are probability density
functions (PDF), with an integral of unity. Statistical analysis was
performed using the Student t-test.
Overlay assays
Expression of the GST- rEAG1 N-terminus was induced in
BL21 (DE3) E. Coli (Stratagene) with 1 mM IPTG. Cells were
harvested after 4 hrs, lysed by short sonication and boiled for
5 min in Laemmli’s loading buffer. Proteins were separated by
SDS-PAGE and either stained with Coomassie brilliant dye or
transferred onto nitrocellulose membranes (GE Healthcare). The
membranes were blocked overnight at 4uC with 5% (w/v) milk
powder in TBS-T (200 mM Tris-HCl pH 7.4, 140 mM NaCl,
0.1% Tween-20), followed by 2 hrs incubation at room temper-
ature with 0.5 mg/ml biotinylated CaM (Calbiochem) and 1 mM
CaCl2 in TBS-T, washed once for 10 min in 0.5% Triton TX-
100, 1 mM CaCl2 in TBS-T and twice for 10 min in 1 mM CaCl2
in TBS-T. Membranes were then incubated for 1 hr with 0.2 mg/
ml HRP-conjugated Streptavidin (Pierce) in TBS-T with 1 mM
CaCl2, washed four times for 5 min in the same buffer and
detected using the Enhanced Chemo-Luminescence kit (ECL, GE
Healthcare).
Calmodulin-hEAG1 Interaction
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A cellular FRET assay for the Ca
2+-dependent interaction
of hEAG1 with CaM
In order to establish a FRET assay for the Ca
2+/CaM-mediated
regulation of hEAG1 in mammalian cells, channel subunits were
fused at their C-terminus to either Cerulean or YFP. The C-
terminal labeling of the channel subunits with fluorescent proteins
(FPs) did not interfere with the intracellular localization and
functionality of the channel. When hEAG1 was fused at the C-
terminus with FPs and expressed in several mammalian cell lines,
its fluorescence signal was located mostly in small vesicles in the
cytoplasm and in the endoplasmic reticulum as well as the
connecting nuclear envelope (Fig 1A). Occasionally, a plasma
membrane staining was discernible as a faint contour line. This
expression pattern was the same as that of non-labelled
overexpressed channels as detected by monoclonal antibodies
recognizing the intracellular part of the channel. The currents and
kinetics of GFP-fused hEAG1 were furthermore indistinguishable
from those of non-labeled channels (data not shown).
In order to characterize the interaction of EAG1 with CaM by
FRET, the truncated cytosolic C-terminus (AA 478–962) was
initially co-expressed with YFP-CaM in HEK cells. The C-
terminus of the channel localized uniformly in the cytoplasm and
was absent from the nucleus, whereas CaM was present in both
these cellular compartments. Optimization experiments showed
that FRET between hEAG1 and CaM could only be measured
when the channel units were labeled at their C-termini with the
donor fluorophore Cerulean and CaM with the acceptor YFP at
its N-terminus, and not vice-versa (data not shown). FRET
measurements with the acceptor photobleaching method require a
molecular excess of the acceptor fluorophore [23], a condition
which was probably not met when CaM was labelled with the
donor. When hEAG1 was labelled with Cerulean, FRET
efficiencies did not depend on the ratio of Cerulean to YFP
fluorescence intensities (See File S1 and Fig. S1), suggesting that
under these experimental conditions there is an excess of the
acceptor fluorophore.
To investigate the Ca
2+-dependency of the hEAG1-CaM
interaction, cells were placed in Ca
2+-containing (1.8 mM Ca
2+)
or Ca
2+-free Ringer solution (1 mM EGTA) and stimulated with
1 mM ionomycin. Cells were fixed and FRET was measured by
the method of acceptor photobleaching (Fig. 1). No differences in
the localization of the constructs were seen upon increasing or
depleting Ca
2+. The FRET measurement revealed that the C-
terminus of the channel interacts with CaM in a Ca
2+-dependent
manner (Fig. 1 A). Cells with increased Ca
2+ concentrations
showed mean FRET efficiencies of 9.5% (61.3% SEM, n=13),
whereas negligible FRET was measured (2.261.6%, n=9) in
Ca
2+-depleted cells (p.0.05). In the cumulative FRET efficiency
distributions of all cells, this is represented by a shift of the FRET
distribution towards zero (Fig. 2 B). This indicates that the C-
terminus of hEAG1 only binds CaM in its Ca
2+-bound state. This
was verified by the use of Ca
2+-insensitive CaM, YFP-apoCaM, as
acceptor. Expression levels of YFP-apoCaM in transfected cells
were similar to those of YFP-CaM (Fig. S2). The FRET efficiency
distribution of apoCaM-co-transfected cells overlaps that of Ca
2+-
depleted cells (1.261.0%, n=13), peaking around zero.
AC a
2+-dependent interaction with CaM was also found for the
full-length hEAG1 channel (Fig. 1). The channel displayed high
FRET efficiencies with YFP-CaM (17.062.8%, n=11) in the
presence of Ca
2+.I nC a
2+-depleted cells, significantly reduced
Figure 1. Visualization of the Ca
2+-dependent interaction of hEAG1-Cerulean with CaM in cells by FRET. Fluorescence intensity and
FRET efficiency (E%) images of HEK-293 transfected with (A) the C-terminus of hEAG1 or (B) the full-length hEAG1 labeled with Cerulean (donor) and
CaM or apoCaM labeled with YFP (acceptor). Cells were stimulated with 1 mM ionomycin in the presence of 1.8 mM Ca
2+ (+Ca
2+) or 1 mM EGTA
(-Ca
2+) for 10 min. FRET was measured by acceptor photobleaching. Bleached areas are indicated by white boxes. FRET efficiencies are shown in
pseudo-color. Scale bars: 5 mm.
doi:10.1371/journal.pone.0010873.g001
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PLoS ONE | www.plosone.org 3 May 2010 | Volume 5 | Issue 5 | e10873Figure 2. Mutation of BD-C2 (F714S, F717S) disrupts the binding of CaM to the truncated C-terminus of hEAG1 but not to the full
channel. The FRET efficiencies of Cerulean-labeled wt-hEAG1 C-terminus and full-length channel upon interaction with YFP-CaM in HEK-293 were
determined by acceptor photobleaching and compared to those of hEAG1 with mutated BD-C2 (F714S, F717S) (A) The average FRET efficiencies (6 SEM)
and (B) Cumulative FRET distribution histograms (probability density function, PDF) of several cells as determined under Ca
2+-rich and depleted conditions.
doi:10.1371/journal.pone.0010873.g002
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Upon co-transfection with YFP-apoCaM, FRET efficiencies were
even reduced further (4.062.3%, n=11), even in the presence of
Ca
2+. The occurrence of detectable FRET even after depletion of
Ca
2+ suggests the presence of minimal amounts of Ca
2+-bound
CaM molecules that mediate the binding to the full-length
channel. Moreover, it indicates that the full-length hEAG1
channel has a higher affinity for Ca
2+/CaM than the truncated
C- terminus alone.
Mutation of the BD-C2 (F714S, F717S) prevents binding
of CaM to the C-terminus but not to the full-length
hEAG1 channel
In order to further investigate the binding of CaM to the C-
terminus, of hEAG1, we introduced the mutations F714S, F717S
in BD-C2 in the truncated C-terminus and full-length construct,
respectively. The expression pattern of the mutated constructs was
not changed in comparison to their wild-type counterparts.
Mutation of BD-C2 fully inhibited the interaction of CaM with
the C-terminus of hEAG1, since no FRET was measured (p.0.05)
under both the high (3.261.5%, n=12) and low Ca
2+ conditions
(1.461.5%, n=11), as well as with apoCaM (0.261.7%, n=10)
(Fig. 2).
However, the full-length channel containing these mutations
interacted with YFP-CaM in the presence of Ca
2+ (8.762.2%,
n=11), as well as upon Ca
2+ depletion (11.562.4%, n=10). The
FRET efficiencies of cells with and without Ca
2+ were not
significantly different. Furthermore, FRET between the BD-C2
mutated channel constructs and YFP-apoCaM was negligible
(2.662.2%, n=9), verifying that the interaction is not due to
binding of Ca
2+-unbound CaM. These results show that the
previously reported mutations in BD-C2 (F714S, F717S) fully
prevent the binding of CaM to the truncated, cytosolic C-terminus
of the hEAG1 and that the intact BD-C1 alone is not sufficient for
CaM binding. However, the mutated full-length protein is still able
to bind CaM, either through BD-N or a combination of BD-N and
BD-C1.
Mutations F151S, A152S prevent the binding of CaM to
the N-terminus of EAG1
Upon closer inspection of the sequence of the N-terminus, two
adjacent putative Ca
2+-dependent CaM-binding motifs of the type
‘‘1-8-14’’ [24] were found at AA 151–164 and 165–178 (Fig. 3 A).
Both sequences are located in a stretch that is predicted to be
amphipathic and composed mostly of basic and hydrophobic
residues. The second putative binding motif contains a proline, an
amino acid that seldom appears in amphipathic helices, although
this does not imply that this site cannot be involved in CaM
binding.
Mutations affecting both 1-8-14 motifs were introduced in a
GST-fusion of the N-terminal segment AA 147–209 of rEAG1 in
order to localize the residues needed for the interaction with CaM
and to determine if both motifs are fully functional. CaM binding
sites of the 1-8-14 type are particularly sensitive to mutations in the
first (position 1) and last (position 14) hydrophobic residues [24].
Three pairs of mutations were inserted. The mutations F151S and
A152S were aimed at disrupting the hydrophobic region at the
beginning of the first 1-8-14 motif (AA 151–165). They should
only affect this first motif and therefore provide information on
whether both or only the first of the putative motifs actively binds
CaM. The middle mutations, V164S and L165S, were introduced
with the intent of disrupting both adjacent 1-8-14 motifs in one
construct. The third pair of mutations - V178S, H179D - target
the last hydrophobic residue of the second putative 1-8-14 binding
site (AA 165–178).
The three constructs thus obtained were expressed in bacteria
and tested biochemically for CaM binding on an overlay blot assay
(Fig. 3 B). Mutants V164S, L165S and V178S, H179D, involving
the second 1-8-14 motif, display a reduced binding to biotinylated
CaM, in comparison to the wild-type GST-N-terminus However,
only the mutation pair F151S, A152S, at the beginning of the first
1-8-14 motif, led to the complete disruption of binding. These
results show that the first 1-8-14 binding motif is the dominant
CaM-binding domain in the N-terminus cytosolic segment of
EAG1.
hEAG1 channels with disrupted BD-N, BD-C2 and intact
BD-C1 are unable to bind CaM
In order to investigate the effect of BD-N on CaM binding,
mutations F151S, A152S were introduced in both wild-type and
BD-C2-mutated hEAG1 and FRET was measured by acceptor
photobleaching in HEK293 cells (Fig. 3 C).
Fusion constructs of the full-length hEAG1 containing only the
BD-N mutations F151S and A152S interacted with YFP-CaM
(9.862.2%, n=10) in the presence of Ca
2+. However, constructs
containing both mutated BD-N and BD-C2 were found not to
interact with YFP-CaM, as no appreciable FRET (2.962.2%,
n=10) could be measured. The combined four mutations F151S,
A152S, F714S, F717S are therefore sufficient to hinder the
binding of CaM to hEAG1 (p.0.05) BD-C1 and other auxiliary
sites can still be involved in the binding mechanism in a
cooperative manner. We conclude that these two CaM binding
sites, the high-affinity 1-8-14 CaM binding domain in the N-
terminus and the previously described C-terminal binding domain
at AA 707-276, are the major binding sites involved in CaM
binding to EAG1.
Discussion
hEAG1 channels are known to be inhibited by Ca
2+/CaM
[1,17,18]. Based on a peptide screen, three CaM binding sites
have been reported, one in the N-terminus (BD-N) and two in the
C-terminus (BD-C1 and BD-C1). Although mutations in all three
domains have been shown to reduce the inhibition of hEAG1
currents by Ca
2+, the participation of the three sites in the direct
binding of CaM to the native channel remained unclear. Here we
describe the use of a FRET-based assay for the characterization of
the binding of CaM to voltage-gated potassium channels hEAG1
in mammalian cells. Using our FRET-based assay we were able to
show that mutations in both the BD-N and BD-C2 CaM-binding
domains were sufficient to fully abolish CaM-binding. This implies
that BD-C1 cannot bind CaM on its own and consequently that
these two binding sites are the two major sites involved in the
direct binding of CaM to native hEAG1 channels.
The relative affinity of the individual CaM binding sites and
their contribution to CaM binding to the native EAG1 channel
was not entirely clear from previous in vitro studies [18]. The
binding affinity for Ca
2+/CaM to BD-N in FCS and Surface
Plasmon Resonance (SPR) studies depended on the length of the
peptides used. BD-N was found to have approximately the same
binding affinity for Ca
2+/CaM as the BD-C2 when GST-fusion
protein segments were used. However, when the FCS assay was
repeated with peptides encoding the minimal CaM-BDs, BD-N
was found to have a higher affinity than that of the C-terminus
(KD=45 and 223 nM, respectively). Our data is clearly in favour
of the latter situation: the channel with intact BD-N was found to
interact with CaM even in Ca
2+-depleted cells, whereas the C-
Calmodulin-hEAG1 Interaction
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This difference probably reflects a higher affinity for Ca
2+/CaM of
BD-N. Typically, 1-8-14-based CaM binding motifs as present in
the BD-N are known to have very high binding affinities for Ca
2+-
bound CaM [24].
The results of the peptide screen were also inconclusive about
the CaM-binding affinity of BD-C1. A low affinity (Kd.5 uM)
was found when using GST-fusion segments, implying that this site
is unable to bind CaM independently. On the other hand, the
binding affinity was higher (KD=327 nM) when using fluores-
cently labeled peptides (,20 AA). Our studies show that the
disruption of BD-N and BD-C2 is sufficient to hinder the binding
of CaM to full-length hEAG1, although we can also not exclude
the possibility that BD-C1 is involved in CaM binding in a
cooperative manner.
The mechanism of CaM inhibition of EAG appears to be
substantially different from that of Ca
2+-activated potassium
channels, which have been shown to constitutively bind CaM
independently of Ca
2+ concentration (see [25,26] for a review).
However, two channel families with structural and functional
similarities to EAG were also found to contain CaM binding
domains, namely Cyclic Nucleotide Gated (CNG) [27,28,29] and
KCNQ channels [30,31]. KCNQ channels constitutively bind
CaM through a IQ-like CaM binding motif [24], CaM bound to
the channel in this manner mediates the inhibition of the channels
by Ca
2+. The mechanism of Ca
2+/CaM regulation of KCNQ
channels is therefore different from that of EAG channels, despite
their structural and electrophysiological similarities. CNG chan-
nels are the closest structural relatives of the EAG channel family.
They share several structural features with EAG including a cyclic-
nucleotide gating domain that, although partially conserved from
a sequence point of view, was found not to be functional in
EAG1[13,14]. The mechanism of CaM/Ca
2+ modulation of CNG
channels is complex and depends on their composition. Olfactory
CNG channels are inhibited primarily by constitutively-bound
CaM through IQ-like domains present in CNGA4 and CNGB1b
subunits [27,32], whereas rod CNG channels are possibly
inhibited through the binding of Ca
2+-associated CaM [27,29].
Figure 3. Mutation of both BD-N and BD-C2 completely disrupt the binding of CaM to full-length hEAG1. (A) Amino acid sequence of
AA 147-209 of EAG1 with the two putative 1-8-14 CaM binding motifs highlighted. (B) CaM overlay blot of the 1-8-14 mutated N-terminus of rEAG1.
Detection with HRP-conjugated streptavidin revealed that mutations F151S, A152S (I) completely disrupted binding of biotinylated CaM whereas
V164S, L165S (II) and V178S, H179D (III) only caused a reduction in binding. (C–E) FRET measurements in cells transfected with YFP-CaM and Cerulean-
labeled full-length hEAG1, mutated in BD-N (F151S, A152S) or in both BD-N and BD-C2 (F151S, A152S, F714S, F717S). Cells were treated with 1 mM
ionomycin in the presence of high Ca
2+. (C) Fluorescence intensity images of Cerulean-hEAG and YFP-CaM after photobleaching and the
corresponding FRET efficiency images in pseudo-color (D) Cumulative FRET distribution histograms (probability density function, PDF) and (E)
average FRET efficiencies (6 SEM) of several cells. Scale bar: 5 mm.
doi:10.1371/journal.pone.0010873.g003
Calmodulin-hEAG1 Interaction
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subunits appears to mediate an intersubunit interaction with the
C-terminus of CNGA1 subunit. Ca
2+/CaM seems to disrupt this
thereby inhibiting the channel [29]. We have investigated if a
similar inhibition mechanism is present in EAG1, however, no
binding of N- and C-terminus was detected on an overlay blot
both in the presence and absence of Ca
2+/CaM (data not shown).
In a different approach, we constructed an intramolecular FRET
sensor where the full-length EAG1 was labeled with donor and
acceptor fluorophores at its cytosolic termini. However, we were
unable to measure differences in FRET efficiency with varying
Ca
2+ concentrations (data not shown).
In summary, the results obtained with our FRET assay
therefore substantiate the previous model of hEAG1 – CaM
interactions and conform to the idea that, under native conditions,
disruption of BD-N and BD-C2 is sufficient to impair the binding
of CaM to the hEAG1 channel.
Supporting Information
Figure S1 hEAG1-CaM FRET efficiencies are not influenced
by fluorescence intensity. Dependence of FRET efficiencies on the
Cerulean/YFP fluorescence intensity ratio (upper panels) and YFP
intensity (lower panels), for representative experiments with full-
length hEAG1 (A–C) and the truncated C-terminal (D–F). Since
PMT gains were optimized for each of the cells imaged, 8-bit pixel
intensity values were divided by PMT voltages in order to
determine an Adjusted Fluorescence Intensity that can be directly
compared between cells. Solid lines represent linear regression fits
of the data and dotted lines represent the confidence interval of the
best-fit line. A goodness-of-fit (r
2) figure is indicated in each plot.
None of the best-fit lines had a slope significantly different from
zero (F-test with zero-slope line as null-hypothesis), indicating that
under the experimental conditions used, and for the range of
fluorophore concentrations present in the samples, FRET
efficiency does not depend on the fluorescence intensities of donor
and acceptor fluorophores.
Found at: doi:10.1371/journal.pone.0010873.s001 (0.85 MB
PDF)
Figure S2 Expression levels of YFP-CaM and YFP-apoCaM are
similar, as determined by fluorescence intensity levels. Average
fluorescence intensities of cells expressing YFP-CaM or YFP-
apoCaM in two representative experiments where both constructs
were co-transfected with Cerulean-tagged C-term. hEAG1 (A) or
C-term hEAG1 with BD-C2 mutations (B). Since PMT gains were
optimized for each of the cells imaged, 8-bit pixel intensity values
were divided by PMT voltages in order to determine an Adjusted
Fluorescence Intensity that can be directly compared between
cells. Laser power was kept constant for each experiment. In
experiment A intensity levels of CaM were slightly higher than
apoCaM (0.4860.02 and 0.3460.02, respectively, p,0.05),
however in experiment B intensity levels of both constructs were
the same.
Found at: doi:10.1371/journal.pone.0010873.s002 (0.18 MB
PDF)
File S1 Supporting discussion.
Found at: doi:10.1371/journal.pone.0010873.s003 (0.04 MB
DOC)
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